These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 28122514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease.
    Gao H, Liu S.
    Life Sci; 2017 Sep 15; 185():23-29. PubMed ID: 28754616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.
    Pawlak K, Mysliwiec M, Pawlak D.
    Thromb Res; 2010 Feb 15; 125(2):e40-5. PubMed ID: 19732942
    [Abstract] [Full Text] [Related]

  • 9. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T.
    Ther Apher Dial; 2011 Apr 15; 15(2):120-4. PubMed ID: 21426500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G, Burtey S, Sallée M.
    Toxins (Basel); 2020 Apr 05; 12(4):. PubMed ID: 32260489
    [Abstract] [Full Text] [Related]

  • 13. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
    Jacobson SH, Egberg N, Hylander B, Lundahl J.
    Am J Nephrol; 2002 Apr 05; 22(1):42-7. PubMed ID: 11919402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC, Tomino Y, Lu KC.
    Toxins (Basel); 2018 Sep 11; 10(9):. PubMed ID: 30208594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Sep 11; 120(6):871-6. PubMed ID: 17331567
    [Abstract] [Full Text] [Related]

  • 20. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
    Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S.
    Sci Rep; 2016 Nov 10; 6():36618. PubMed ID: 27830716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.